Report Summary
Eternity Insights has published a new study on Global Platelet Rich Plasma (PRP) Market focusing on key segments as by Type (Pure PRP,Leukocyte-Rich PRP,Leukocyte-Rich Fibrin, Other), by Application (Orthopedics,Cosmetic Surgery & Dermatology,Ophthalmic Surgery,Neurosurgery,General surgery,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Platelet Rich Plasma (PRP) Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Platelet Rich Plasma (PRP) Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Platelet Rich Plasma (PRP) Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Platelet Rich Plasma (PRP) Market Segmentation:
Platelet Rich Plasma (PRP) Market, By Type
- Pure PRP
- Leukocyte-Rich PRP
- Leukocyte-Rich Fibrin
- Other
Platelet Rich Plasma (PRP) Market, By Application
- Orthopedics
- Cosmetic Surgery & Dermatology
- Ophthalmic Surgery
- Neurosurgery
- General surgery
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Platelet Rich Plasma (PRP) market in terms of demand generation. The Platelet Rich Plasma (PRP) market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Platelet Rich Plasma (PRP) market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Platelet Rich Plasma (PRP) Market Taxonomy:
To learn more about this report
Global Platelet Rich Plasma (PRP) Market Competitive Landscape
The global Platelet Rich Plasma (PRP) market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- AdiStem Ltd.
- Arthrex
- Inc.
- Biomet
- Inc.
- Cesca Therapeutics
- Inc.
- DePuy Synthes
- Inc.
- EmCyte Corporation
- Exactech
- Inc.
- Harvest Technologies Corp.
- Nuo Therapeutics
- Inc.
- Regen Lab SA
- Stryker Corporation
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Pure PRP,Leukocyte-Rich PRP,Leukocyte-Rich Fibrin, Other |
| By Application Outlook |
Orthopedics,Cosmetic Surgery & Dermatology,Ophthalmic Surgery,Neurosurgery,General surgery,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
AdiStem Ltd.,Arthrex, Inc.,Biomet, Inc.,Cesca Therapeutics, Inc.,DePuy Synthes, Inc.,EmCyte Corporation,Exactech, Inc.,Harvest Technologies Corp.,Nuo Therapeutics, Inc.,Regen Lab SA,Stryker Corporation |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Platelet Rich Plasma (PRP) Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Platelet Rich Plasma (PRP) Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Platelet Rich Plasma (PRP) Industry Overview
2.1 Global Platelet Rich Plasma (PRP) Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Platelet Rich Plasma (PRP) Global Import Market Analysis
2.1.2 Platelet Rich Plasma (PRP) Global Export Market Analysis
2.1.3 Platelet Rich Plasma (PRP) Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Pure PRP
2.2.2 Leukocyte-Rich PRP
2.2.3 Leukocyte-Rich Fibrin
2.3.2 Cosmetic Surgery & Dermatology
2.3.3 Ophthalmic Surgery
2.3.4 Neurosurgery
2.3.5 General surgery
2.3.6 Others
2.4.2 Global Platelet Rich Plasma (PRP) Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Platelet Rich Plasma (PRP) Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Platelet Rich Plasma (PRP) Manufacturer Market Share
2.4.5 Top 10 Platelet Rich Plasma (PRP) Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Platelet Rich Plasma (PRP) Market
2.4.7 Key Manufacturers Platelet Rich Plasma (PRP) Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Platelet Rich Plasma (PRP) Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Platelet Rich Plasma (PRP) Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Platelet Rich Plasma (PRP) Market Size Categorized by Regions
4.1 Global Platelet Rich Plasma (PRP) Revenue, Sales and Market Share by Regions
4.1.1 Global Platelet Rich Plasma (PRP) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Platelet Rich Plasma (PRP) Revenue and Market Share by Regions (2015-2020)
4.2 Europe Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
4.3 APAC Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
4.4 North America Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
4.5 South America Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
5 Europe Platelet Rich Plasma (PRP) Market Size Categorized by Countries
5.1 Europe Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Countries
5.1.1 Europe Platelet Rich Plasma (PRP) Sales by Countries (2015-2020)
5.1.2 Europe Platelet Rich Plasma (PRP) Revenue by Countries (2015-2020)
5.1.3 Germany Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
5.1.4 UK Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
5.1.5 France Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
5.1.6 Russia Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
5.1.7 Italy Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
5.1.8 Spain Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
5.2 Europe Platelet Rich Plasma (PRP) Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Platelet Rich Plasma (PRP) Sales Market Share by Type (2015-2020)
5.3.2 Europe Platelet Rich Plasma (PRP) Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Platelet Rich Plasma (PRP) Sales Market Share by Application (2015-2020)
6 Asia-Pacific Platelet Rich Plasma (PRP) Market Size Categorized by Countries
6.1 Asia-Pacific Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Platelet Rich Plasma (PRP) Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Platelet Rich Plasma (PRP) Revenue by Countries (2015-2020)
6.1.3 China Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
6.1.4 Japan Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
6.1.5 Korea Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
6.1.6 India Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
6.1.8 Australia Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Platelet Rich Plasma (PRP) Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Platelet Rich Plasma (PRP) Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Platelet Rich Plasma (PRP) Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Platelet Rich Plasma (PRP) Sales and Market Share by Application (2015-2020)
7 North America Platelet Rich Plasma (PRP) Market Size Categorized by Countries
7.1 North America Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Countries
7.1.1 North America Platelet Rich Plasma (PRP) Sales by Countries (2015-2020)
7.1.2 North America Platelet Rich Plasma (PRP) Revenue by Countries (2015-2020)
7.1.3 United States Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
7.1.4 Canada Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
7.1.5 Mexico Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
7.2 North America Platelet Rich Plasma (PRP) Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Platelet Rich Plasma (PRP) Sales Market Share by Type (2015-2020)
7.3.2 North America Platelet Rich Plasma (PRP) Revenue and Revenue Share by Type (2015-2020)
7.4 North America Platelet Rich Plasma (PRP) Sales Market Share by Application (2015-2020)
8 South America Platelet Rich Plasma (PRP) Market Size Categorized by Countries
8.1 South America Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Countries
8.1.1 South America Platelet Rich Plasma (PRP) Sales by Countries (2015-2020)
8.1.2 South America Platelet Rich Plasma (PRP) Revenue by Countries (2015-2020)
8.1.3 Brazil Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
8.2 South America Platelet Rich Plasma (PRP) Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Platelet Rich Plasma (PRP) Sales Market Share by Type (2015-2020)
8.3.2 South America Platelet Rich Plasma (PRP) Revenue and Revenue Share by Type (2015-2020)
8.4 South America Platelet Rich Plasma (PRP) Sales Market Share by Application (2015-2020)
9 Middle East and Africa Platelet Rich Plasma (PRP) Market Size Categorized by Countries
9.1 Middle East and Africa Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Platelet Rich Plasma (PRP) Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Platelet Rich Plasma (PRP) Revenue by Countries (2015-2020)
9.1.3 GCC Countries Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
9.1.4 Turkey Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
9.1.5 Egypt Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
9.1.6 South Africa Platelet Rich Plasma (PRP) Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Platelet Rich Plasma (PRP) Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Platelet Rich Plasma (PRP) Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Platelet Rich Plasma (PRP) Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Platelet Rich Plasma (PRP) Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Platelet Rich Plasma (PRP) Sales Market Share by Application (2015-2020)
10 Global Platelet Rich Plasma (PRP) Market Segment by Type
10.1 Global Platelet Rich Plasma (PRP) Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Platelet Rich Plasma (PRP) Sales and Market Share by Type (2015-2020)
10.1.2 Global Platelet Rich Plasma (PRP) Revenue and Market Share by Type (2015-2020)
10.2 Pure PRP Sales Growth Rate and Price
10.2.1 Global Pure PRP Sales Growth Rate (2015-2020)
10.2.2 Global Pure PRP Price (2015-2020)
10.3 Leukocyte-Rich PRP Sales Growth Rate and Price
10.3.1 Global Leukocyte-Rich PRP Sales Growth Rate (2015-2020)
10.3.2 Global Leukocyte-Rich PRP Price (2015-2020)
10.4 Leukocyte-Rich Fibrin Sales Growth Rate and Price
10.4.1 Global Leukocyte-Rich Fibrin Sales Growth Rate (2015-2020)
10.4.2 Global Leukocyte-Rich Fibrin Price (2015-2020)
11.1 Global Platelet Rich Plasma (PRP)Sales Market Share by Application (2015-2020)
11.2 Orthopedics Sales Growth Rate (2015-2020)
11.3 Cosmetic Surgery & Dermatology Sales Growth Rate (2015-2020)
11.4 Ophthalmic Surgery Sales Growth Rate (2015-2020)
11.5 Neurosurgery Sales Growth Rate (2015-2020)
11.6 General surgery Sales Growth Rate (2015-2020)
11.7 Others Sales Growth Rate (2015-2020)
12.1 Global Platelet Rich Plasma (PRP) Revenue, Sales and Growth Rate (2020-2027)
12.2 Platelet Rich Plasma (PRP) Market Forecast by Regions (2020-2027)
12.2.1 Europe Platelet Rich Plasma (PRP) Market Forecast (2020-2027)
12.2.2 APAC Platelet Rich Plasma (PRP) Market Forecast (2020-2027)
12.2.3 North America Platelet Rich Plasma (PRP) Market Forecast (2020-2027)
12.2.4 South America Platelet Rich Plasma (PRP) Market Forecast (2020-2027)
12.2.5 Middle East & Africa Platelet Rich Plasma (PRP) Market Forecast (2020-2027)
12.3 Platelet Rich Plasma (PRP) Market Forecast by Type (2020-2027)
12.3.1 Global Platelet Rich Plasma (PRP) Sales Forecast by Type (2020-2027)
12.3.2 Global Platelet Rich Plasma (PRP) Market Share Forecast by Type (2020-2027)
12.4 Platelet Rich Plasma (PRP) Market Forecast by Application (2020-2027)
12.4.1 Global Platelet Rich Plasma (PRP) Sales Forecast by Application (2020-2027)
12.4.2 Global Platelet Rich Plasma (PRP) Market Share Forecast by Application (2020-2027)
13 Analysis of Platelet Rich Plasma (PRP) Industry Key Manufacturers
13.1 AdiStem Ltd.
13.1.1 Company Details
13.1.2 Product Information
13.1.3 AdiStem Ltd. Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 AdiStem Ltd. News
13.2 Arthrex, Inc.
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Arthrex, Inc. Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Arthrex, Inc. News
13.3 Biomet, Inc.
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Biomet, Inc. Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Biomet, Inc. News
13.4 Cesca Therapeutics, Inc.
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Cesca Therapeutics, Inc. Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Cesca Therapeutics, Inc. News
13.5 DePuy Synthes, Inc.
13.5.1 Company Details
13.5.2 Product Information
13.5.3 DePuy Synthes, Inc. Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 DePuy Synthes, Inc. News
13.6 EmCyte Corporation
13.6.1 Company Details
13.6.2 Product Information
13.6.3 EmCyte Corporation Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 EmCyte Corporation News
13.7 Exactech, Inc.
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Exactech, Inc. Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Exactech, Inc. News
13.8 Harvest Technologies Corp.
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Harvest Technologies Corp. Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Harvest Technologies Corp. News
13.9 Nuo Therapeutics, Inc.
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Nuo Therapeutics, Inc. Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Nuo Therapeutics, Inc. News
13.10 Regen Lab SA
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Regen Lab SA Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Regen Lab SA News
13.11 Stryker Corporation
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Stryker Corporation Platelet Rich Plasma (PRP) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Stryker Corporation News
15 Appendix